The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation
Authors:
- Ralf ZarbockRZRalf Zarbock
- Markus WoischnikMWMarkus Woischnik
- Christiane SparrCSChristiane Sparr
- Tobias ThurmTTTobias Thurm
- Sunčana KernSKSunčana Kern
- Eva KaltenbornEKEva Kaltenborn
- Andreas HectorAHAndreas Hector
- Dominik HartlDHDominik Hartl
- Gerhard LiebischGLGerhard Liebisch
- Gerd SchmitzGSGerd Schmitz
- Matthias GrieseMGMatthias Griese
Open Access
- 29 March 2012
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 12 (1) , 15
Abstract
Background: Surfactant protein C (SP-C) is important for the function of pulmonary surfactant. Heterozygous mutations inSFTPC, the gene encoding SP-C, cause sporadic and familial interstitial lung disease (ILD) in children and adults. Mutations mapping to the BRICHOS domain located within the SP-C proprotein result in perinuclear aggregation of the proprotein. In this study, we investigated the effects of the mutation A116D in the BRICHOS domain of SP-C on cellular homeostasis. We also evaluated the ability of drugs currently used in ILD therapy to counteract these effects.Methods: SP-CA116Dwas expressed in MLE-12 alveolar epithelial cells. We assessed in vitro the consequences for cellular homeostasis, immune response and effects of azathioprine, hydroxychloroquine, methylprednisolone and cyclophosphamide.Results: Stable expression of SP-CA116Din MLE-12 alveolar epithelial cells resulted in increased intracellular accumulation of proSP-C processing intermediates. SP-CA116Dexpression further led to reduced cell viability and increased levels of the chaperones Hsp90, Hsp70, calreticulin and calnexin. Lipid analysis revealed decreased intracellular levels of phosphatidylcholine (PC) and increased lyso-PC levels. Treatment with methylprednisolone or hydroxychloroquine partially restored these lipid alterations. Furthermore, SP-CA116Dcells secreted soluble factors into the medium that modulated surface expression of CCR2 or CXCR1 receptors on CD4+lymphocytes and neutrophils, suggesting a direct paracrine effect of SP-CA116Don neighboring cells in the alveolar space.Conclusions: We show that the A116D mutation leads to impaired processing of proSP-C in alveolar epithelial cells, alters cell viability and lipid composition, and also activates cells of the immune system. In addition, we show that some of the effects of the mutation on cellular homeostasis can be antagonized by application of pharmaceuticals commonly applied in ILD therapy. Our findings shed new light on the pathomechanisms underlying SP-C deficiency associated ILD and provide insight into the mechanisms by which drugs currently used in ILD therapy act.Keywords
This publication has 48 references indexed in Scilit:
- On the fate of early endosomesBiological Chemistry, 2009
- Mutations linked to interstitial lung disease can abrogate anti-amyloid function of prosurfactant protein CBiochemical Journal, 2008
- Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infectionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Interstitial lung diseases in infants and children: Fig. 1—European Respiratory Journal, 2008
- The activities and function of molecular chaperones in the endoplasmic reticulumSeminars in Cell & Developmental Biology, 2007
- Regulation of surfactant secretion in alveolar type II cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Neutrophils and immunity: challenges and opportunitiesNature Reviews Immunology, 2006
- ABCA3Gene Mutations in Newborns with Fatal Surfactant DeficiencyNew England Journal of Medicine, 2004
- Chloroquine as intercalator: a hypothesis revivedParasitology Today, 1990
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959